(PharmaNewsWire.Com, September 09, 2019 ) The Research Report on European Mammography Workstations Market provides a detailed overview of Factors such as the rising burden of breast cancer, increasing market availability of multimodality diagnostic platforms, and the increasing patient awareness about the clinical benefits associated with the early diagnosis of breast conditions are driving the growth of the market.
The report "European Mammography Workstations Market by Modality (Multimodal, Standalone), Application (Diagnosis, Advanced Imaging, Clinical Review), End User (Hospital, Breast Care Centers, Academia), Country (Germany, UK, France, Italy, Spain) - Forecast to 2024" The European mammography workstations market is projected to reach USD 14 million by 2024 from USD 10 million in 2018, at a CAGR of 5.5% during the forecast period.
European Mammography Workstations Market Based on Modality;
On the basis of modality, the European mammography workstations market is segmented into mammography (X-ray) workstations and multimodality mammography workstations. In 2018, the multimodality mammography workstations segment accounted for the larger share of the market. This can be attributed to the increasingly supportive government initiatives/regulations in Europe, increasing awareness about the diagnostic efficacy of contrast-enhanced digital mammography, growing market availability of integrated mammography solutions, techno-commercial advantages associated with multimodality mammography workstations, and the rising prevalence of breast cancer.
European Mammography Workstations Market Based on Applications;
On the basis of applications, the market is segmented into diagnostic screening, advanced imaging, and clinical review. The diagnostic screening segment accounted for the largest share of the market in 2018, and this trend is expected to continue during the forecast period. This can be attributed to the ongoing market transition from 2D to 3D clinical diagnostics; the market shift from single-modality workstations to multimodality diagnostic imaging; greater integration of key diagnostic imaging modalities with PACS, artificial intelligence (AI), and cloud-based platforms across mature countries; and the large end-user base for mammography in Europe coupled with their ongoing integration with imaging workstations across key countries.
Germany accounted for the largest share of the European mammography workstations market in 2018. The large share of Germany is primarily attributed to the better reimbursement scenario in the country as compared to other European countries, wider acceptance of multimodality mammography workstations among major end users (such as hospitals, surgical clinics, and breast care centers), and the rising patient demand for improved cancer screening.
Major Key Market Players:
General Electric (US), Koninklijke Philips N.V. (Netherlands), Hologic Inc. (US), Siemens (Germany), and FUJIFILM Corporation (Japan) are the major players in the European mammography workstations market. Other prominent players in this market include Carestream Health (US), EIZO Corporation (Japan), Agfa-Gevaert Group (Belgium), Barco (Belgium), Konica Minolta, Inc. (Japan), Benetec Advanced Medical Systems (Belgium), PLANMED OY (Finland), Sectra AB (Sweden), Aycan Medical Systems, LLC. (US), and Esaote SPA (Italy).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
